Novavax (WBO:NVAX) Beginning Cash Position : €504 Mil (As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Novavax Beginning Cash Position?

Novavax's Beginning Cash Position for the quarter that ended in Mar. 2025 was €504 Mil.

Novavax's quarterly Beginning Cash Position declined from Sep. 2024 (€627 Mil) to Dec. 2024 (€562 Mil) and declined from Dec. 2024 (€562 Mil) to Mar. 2025 (€504 Mil).

Novavax's annual Beginning Cash Position declined from Dec. 2022 (€1,443 Mil) to Dec. 2023 (€1,237 Mil) and declined from Dec. 2023 (€1,237 Mil) to Dec. 2024 (€558 Mil).

Novavax Beginning Cash Position Historical Data

The historical data trend for Novavax's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novavax Beginning Cash Position Chart

Novavax Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

67.55

574.13

1,442.68

1,236.89

557.54

Novavax Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Beginning Cash Position	Get a 7-Day Free Trial															537.11	460.72	626.70	562.10	504.39

Novavax Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Novavax Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Novavax's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Novavax Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novavax Inc (WBO:NVAX) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

NVAX:USA NVAX:Mexico NVV1:Germany NVV1:Germany NVV1:Germany NVV1:Bulgaria

Address

700 Quince Orchard Road, Gaithersburg, MD, USA, 20878

Website

https://www.novavax.com

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.